Diabet2 s.r.o.

At Diabet2 s.r.o. in Prague, clinical trials in cardiovascular diseases focus on people at high risk of serious heart and blood vessel events. The studies are designed to evaluate whether new therapies can better prevent outcomes such as heart attack, stroke, and other major vascular complications.

• Atherosclerotic cardiovascular disease and related high-risk heart conditions
• Elevated lipoprotein(a) as a target for reducing cardiovascular risk
• Testing treatments intended to lower the chance of major events like myocardial infarction and ischemic stroke

The research includes adults with established or elevated atherosclerotic cardiovascular disease risk, with the goal of improving long-term prevention and treatment effectiveness.

Another major area at this site is nutritional and metabolic diseases, with trials centered on type 2 diabetes mellitus, obesity, and overweight. These studies look at whether newer therapies can improve blood sugar control, support weight loss, and help manage cardiometabolic risk.

• Type 2 diabetes with overweight or obesity
• Evaluating treatments that may improve HbA1c and overall metabolic health
• Studying approaches that combine diabetes care with weight management

The clinical research at Diabet2 s.r.o. reflects a strong interest in therapies that address both diabetes and the broader metabolic conditions often linked to it.